Healthcare Innovation August 15, 2024
Pietje Kobus

“In our first year of negotiations, we are saving Medicare an estimated $6 billion,” says HHS Secretary Xavier Becerra

In an August 15 press release, the Centers for Medicare and Medicaid Services (CMS) announced that the Biden-Harris Administration has reached an agreement for new, lower prices for all ten drugs selected for negotiations in anticipation of lowering prescription drug prices.

Per the news release, “These negotiated drugs are some of the most expensive and most frequently dispensed drugs in the Medicare program and are used to treat conditions such as heart disease, diabetes, and cancer. The new prices will go into effect for people with Medicare Part D prescription drug coverage beginning January...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Pharma, Pharma / Biotech
Podcast: The Scope of Medicare Fraud
A Stronger Medicare Program—Now And Into The Future
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
ACOs Saved Billions in 2023: Can They Sustain This Beyond 2025?
Telehealth under threat: Why Congress must act to save Medicare coverage [PODCAST]

Share This Article